HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,429,047 | +27.7% | 80,512 | +42.1% | 0.15% | +33.9% |
Q1 2024 | $1,902,139 | -12.6% | 56,645 | -15.9% | 0.11% | -13.5% |
Q4 2023 | $2,175,534 | -34.3% | 67,354 | -33.4% | 0.13% | -40.0% |
Q3 2023 | $3,312,850 | -8.2% | 101,094 | -1.4% | 0.21% | +2.4% |
Q2 2023 | $3,608,735 | -8.3% | 102,550 | -14.9% | 0.20% | -8.1% |
Q1 2023 | $3,934,064 | -13.3% | 120,492 | +46.4% | 0.22% | -14.2% |
Q4 2022 | $4,535,722 | -3.5% | 82,318 | -22.4% | 0.26% | -4.8% |
Q3 2022 | $4,700,000 | -10.4% | 106,127 | -1.3% | 0.27% | +7.5% |
Q2 2022 | $5,245,000 | -12.8% | 107,538 | -13.1% | 0.25% | +5.8% |
Q1 2022 | $6,017,000 | +2.5% | 123,682 | -10.1% | 0.24% | +15.4% |
Q4 2021 | $5,869,000 | +10.0% | 137,646 | -1.1% | 0.21% | +5.6% |
Q3 2021 | $5,336,000 | +34.6% | 139,214 | -0.9% | 0.20% | +39.7% |
Q2 2021 | $3,965,000 | -18.3% | 140,438 | -4.4% | 0.14% | -10.8% |
Q1 2021 | $4,854,000 | +291.8% | 146,905 | +328.6% | 0.16% | +259.1% |
Q4 2020 | $1,239,000 | – | 34,275 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $545,757,000 | 83.25% |
Nan Fung Group Holdings Ltd | 768,708 | $37,398,000 | 17.74% |
venBio Partners LLC | 1,544,484 | $75,139,000 | 16.66% |
Vivo Capital, LLC | 4,570,148 | $222,338,000 | 15.31% |
HealthInvest Partners AB | 120,000 | $5,838,000 | 9.30% |
Aisling Capital Management LP | 342,815 | $16,678,000 | 9.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 205,474 | $20,533,000 | 4.63% |
ASHFORD CAPITAL MANAGEMENT INC | 659,873 | $32,103,000 | 3.46% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $14,595,000 | 2.92% |
Newlight Partners LP | 651,372 | $31,689,000 | 2.15% |